Share Email Print

Proceedings Paper

Using optical coherence tomography (OCT) for quantitative measurement of attenuation coefficients of the arterial wall
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The feasibility to detect and characterize vulnerable plaques by Optical Coherence Tomography (OCT) is currently under investigation. It has been shown that in some cases, by using qualitative criteria, the OCT images can be used to differentiate between different types of plaque. However, the quality of the image and the experience of the observer greatly influences the interpretation of the images, which indicates the necessity of a quantitative analysis of the OCT data. As OCT measures the depth resolved backscattering it is possible to calculate the light attenuation coefficient (μt) in the different areas in the image and use that to identify the different plaque constituents in the target tissue. In this study, we present in vitro data on μt, measured in atherosclerotic lesions.

Paper Details

Date Published: 12 September 2003
PDF: 5 pages
Proc. SPIE 4949, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII, (12 September 2003); doi: 10.1117/12.477883
Show Author Affiliations
Freek J. van der Meer, Academic Medical Ctr./Univ. Amsterdam (Netherlands)
Dirk J. Faber, Academic Medical Ctr./Univ. Amsterdam (Netherlands)
Maurice C.G. Aalders, Academic Medical Ctr./Univ. Amsterdam (Netherlands)
Ton G. J. M. van Leeuwen, Academic Medical Ctr./Univ. Amsterdam (Netherlands)
Biomedical Technology Institute/Univ. of Twente (Netherlands)

Published in SPIE Proceedings Vol. 4949:
Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII
Eugene A. Trowers M.D.; Lawrence S. Bass M.D.; Udayan K. Shah M.D.; Reza S. Malek M.D.; David S. Robinson M.D.; Kenton W. Gregory M.D.; Lawrence S. Bass M.D.; Abraham Katzir; Nikiforos Kollias; Hans-Dieter Reidenbach; Brian Jet-Fei Wong M.D.; Timothy A. Woodward M.D.; Werner T.W. de Riese; Keith D. Paulsen, Editor(s)

© SPIE. Terms of Use
Back to Top